VOICED : Moderna anuncia que su vacuna contra el covid-19 es eficaz en niños de 6 a 11 años

Moderna announced positive results for its COVID-19 vaccine in children aged 6-11, showing a strong immune response and a favorable safety profile. Most adverse effects were mild or moderate. Moderna plans to submit the data for global regulatory approval. Meanwhile, US advisors are set to discuss the authorization of the Pfizer-BioNTech vaccine for children aged 5-11.

What new insight or understanding did you gain from this video?